Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clemastine for Pitt-Hopkins syndrome
NL-OMON61042Phase 2Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Pitt-Hopkins syndrome (PTHS) comparing Clemastine with Placebo (2 arms). Primary endpoint: Caretaker Global Impression rating scale. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
clemastine
03
Conditions
Pitt-Hopkins syndrome (PTHS)
Beyond the preview
Go deeper on NL-OMON61042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61042.